A prospective double-blind, randomized, placebo-controlled study to evaluate the efficacy of silodosin 8 mg as an on-demand, reversible, nonhormonal oral contraceptive for males: a pilot study.

Published in: World journal of urology (2019)

Silodosin 8 mg achieved total reversible azoospermia, hence prevented unintended pregnancies in the female partners of the males who used the drug as an on-demand oral contraceptive.

Keyphrases

double blind
placebo controlled
clinical trial
lower urinary tract symptoms
benign prostatic hyperplasia
phase iii
phase ii
study protocol
open label
preterm birth
human immunodeficiency virus
hepatitis c virus
pregnant women
gestational age
hiv infected
pregnancy outcomes